Table 2 Allelic variation measured at 6 microsatellite markers for AML patients with regional lymph nodal involvement.
Microsatellite markers | RH68414 | SHGC-30026 | Csnpnthl1-pcr1–1 | GDB:378419 | STS-L48546 | D16S3394 | |
|---|---|---|---|---|---|---|---|
Patient1 | T1 | + | ++ | +++ | ++++ | + | ++ |
T2 | + | ++ | ++ | +++ | + | ++ | |
Patient2 | T1 | + | +++ | + | +++ | + | +++ |
T2 | + | ++ | + | +++ | + | ++ | |
Patient3 | T1 | + | ++ | ++ | +++++ | + | +++ |
T2 | + | ++ | ++ | ++++ | + | +++ | |
Patient4 | T1 | + | ++ | +++ | +++++ | + | +++ |
T2 | + | ++ | ++ | +++ | + | +++ | |
Patient5 | T1 | +++ | ++ | ++ | +++ | + | ++ |
T2 | + | ++ | ++ | +++ | + | ++ | |
Patient6 | T1 | + | ++ | + | +++ | + | ++ |
T2 | + | ++ | + | +++ | + | ++ | |
Patient7 | T1 | ++ | ++ | +++ | ++++ | ++++ | ++ |
T2 | + | ++ | +++ | ++++ | ++++ | ++ | |
Patient8 | T1 | + | ++ | +++ | +++ | + | ++ |
T2 | + | ++ | ++ | +++ | + | ++ | |
Patient9 | T1 | + | ++ | + | +++ | + | ++ |
T2 | + | + | + | +++ | + | + | |
Patient10 | T1 | + | ++ | + | +++ | + | ++ |
T2 | + | ++ | + | +++ | + | ++ | |
Patient11 | T1 | ++ | + | − | − | + | + |
T2 | + | + | − | − | + | + | |
Patient12 | T1 | + | ++ | ++++ | +++ | +++ | +++ |
T2 | + | ++ | +++ | +++ | ++ | +++ | |
Changes/tumor pair | 3/12(25%) | 2/12(16.7%) | 4/12(33.3%) | 3/12(25%) | 1/12(8.3%) | 2/12(16.7%) | |
